Considering that serum ADIPOQ concentration and its skin expression were altered in obesity, these findings suggest that ADIPOQ’s effects on skin are at least in part regulated by the reduced expression of ADIPOR2. The gene discussed is ADIPOR2; the disease is obesity due to melanocortin 4 receptor deficiency.